Financhill
Buy
59

UTHR Quote, Financials, Valuation and Earnings

Last price:
$510.30
Seasonality move :
5.61%
Day range:
$510.64 - $519.65
52-week range:
$266.98 - $519.65
Dividend yield:
0%
P/E ratio:
19.47x
P/S ratio:
7.92x
P/B ratio:
3.36x
Volume:
411K
Avg. volume:
486.3K
1-year change:
42.89%
Market cap:
$22.1B
Revenue:
$2.9B
EPS (TTM):
$26.39

UTHR Analysts' Consensus Rating

The 13 analysts providing 12-month price projections for United Therapeutics Corp. shares anticipate an average target of $518.25, ranging from a low estimate of $423.00 to a high estimate of $600.00. This average target implies a growth of 0.87% compared to the current stock price of $513.79.

Consensus Price Target

$518.25

Highest Price Target

$600.00

Lowest Price Target

$423.00

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Analyst Ratings

6M Ago 1M Ago Current
Buy 7 8 8

Hold 6 5 5

Sell 0 0 0
Consensus Buy Buy Buy

UTHR Recommendation Trends

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Is Bloom Energy The Best Stock to Buy Now?
Is Bloom Energy The Best Stock to Buy Now?

Shares of energy startup Bloom Energy (NYSE:BE) have advanced by…

Stock Ideas

Buy
55
Is NVDA Stock a Buy?

Market Cap: $4.5T
P/E Ratio: 63x

Buy
53
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 36x

Buy
59
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
60
AAOI alert for Dec 23

Applied Optoelectronics, Inc. [AAOI] is up 3.95% over the past day.

Buy
52
ABVX alert for Dec 23

Abivax SA [ABVX] is down 0.27% over the past day.

Buy
60
ZBIO alert for Dec 23

Zenas BioPharma, Inc. [ZBIO] is up 1.18% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock